Skip to main content
SunBio, Inc. logo

SunBio, Inc. — Investor Relations & Filings

Ticker · 067370 ISIN · KR7067370007 KO Manufacturing
Open in API
Filings indexed 213 across all filing types
Latest filing 2020-03-06 Audit Report / Informat…
Country KR South Korea
Listing KO 067370

About SunBio, Inc.

http://www.sunbio.com/

SunBio, Inc. is a biotechnology company that develops biosimilars, biopharmaceuticals, and medical devices. The company's core activities are based on its proprietary PEGylation technology, a process that modifies molecules to enhance their therapeutic properties. SunBio's product portfolio includes PEG reagents for research and drug delivery, as well as biopharmaceutical candidates. Key development projects include MucoPEG™, a muco-adhesive hydrogel, and SBX, an artificial blood substitute. The company positions itself as a specialist in PEGylation, creating advanced therapeutic products for a global market.

Recent filings

Filing Released Lang Actions
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a short regulatory filing (931 characters) titled '감사보고서 제출' (Submission of Audit Report). It provides a summary table of audit opinions and key financial figures (assets, liabilities, revenue, etc.) as required by regulatory disclosure rules in Korea. Since it is a brief summary announcement of the audit results rather than the full, comprehensive audit report document, it falls under the category of a regulatory filing announcement. FY 2019
2020-03-06 Korean
주주총회소집결의
AGM Information Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집 결의) for SunBio, detailing the date, location, and agenda items (financial statements, director/auditor compensation). This type of document is a standard proxy solicitation or notice of meeting sent to shareholders to inform them of upcoming votes, which falls under the Proxy Solicitation & Information Statement category.
2020-03-04 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 1% confidence The document is a short regulatory announcement regarding the suspension of share registration (closing of the shareholder register) for the purpose of determining shareholders for an upcoming Annual General Meeting. It does not contain the full report or meeting materials, but rather serves as a formal regulatory notice of a corporate action. Given it does not fit into specific categories like dividend announcements or share buybacks, it falls under the general regulatory filing category.
2019-12-12 Korean
기타주요경영사항(자율공시)(구강건조증치료제(MucoPEG) 미국 FDA의 판매허가 취득)
Regulatory Filings Classification · 1% confidence The document is a short, formal announcement regarding a specific regulatory event (FDA market clearance for a product). It is titled 'Other Major Management Matters' (a standard Korean regulatory disclosure format) and provides details on the approval of a medical device. Since it is a regulatory disclosure of a specific event rather than a full financial report, and it does not fit into the specific categories like M&A or Dividend, it falls under the general regulatory filing category.
2019-11-06 Korean
기업설명회(IR)개최결과
Regulatory Filings Classification · 1% confidence The document is a formal notification of the results of an Investor Relations (IR) meeting held by SunBio. It provides details such as the date, location, attendees, and a summary of the agenda (company introduction, business outlook, and Q&A). It does not contain the actual presentation slides or detailed financial data, but rather serves as a regulatory disclosure confirming the event took place. Under the 'Menu vs Meal' rule, this is an announcement of an event/report rather than the investor presentation itself, and it fits the criteria for a general regulatory filing. FY 2019
2019-10-23 Korean
기업설명회(IR)개최
Investor Presentation Classification · 1% confidence The document is a short announcement (924 characters) regarding the scheduling of an upcoming Investor Relations (IR) meeting. It provides details such as the date, location, purpose, and contact information for the event. Since it is an announcement of an event rather than the presentation materials themselves, and it does not fit into specific categories like 'Call Transcript' or 'Annual Report', it is classified as a Regulatory Filing (RNS) as it serves as a formal notice of a corporate event.
2019-10-10 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.